The European Medicines Agency has replaced the activities of the two working parties of the Committee for Advanced Therapies (CAT) – the Cell-based Products Working Party (CPWP) and Gene Therapy Working Party (GTWP) – with ad-hoc drafting groups.
Go to Source

This entry was posted on Saturday, October 13th, 2012 at 11:30 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.